Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Resin Infiltration Versus Microabrasion With CPP-ACP for Fluorotic White Spot Lesions

10 luglio 2026 aggiornato da: Le Van Nhat Thang, Hue University of Medicine and Pharmacy

Resin Infiltration Versus Microabrasion Combined With CPP-ACP for Masking Fluorotic Anterior White Spot Lesions: A 6-Month Randomized Controlled Clinical Trial

Dental fluorosis can cause visible chalky-white spots on the front teeth. These white spot lesions may affect dental appearance even when the tooth surface is intact.

This randomized clinical trial compared two minimally invasive approaches for masking fluorotic white spot lesions on permanent anterior teeth. Eligible teeth were randomly assigned to receive either resin infiltration or enamel microabrasion followed by application of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP).

The main outcomes were the color difference between the white spot lesion and the surrounding sound enamel and the proportion of the visible tooth surface occupied by the lesion. These outcomes were evaluated from standardized clinical photographs before treatment, after treatment, and during follow-up through 6 months.

Panoramica dello studio

Descrizione dettagliata

This was a prospective, controlled, two-arm randomized clinical trial conducted at the Dental Clinic of the University of Medicine and Pharmacy Hospital, Hue University, Vietnam, between June 2023 and June 2025. Patients with fluorotic white spot lesions on permanent anterior teeth were enrolled. Eligible lesions were shallow, chalky-white enamel opacities confined to the outer enamel and clinically consistent with dental fluorosis.

Randomization was performed at the tooth level. A total of 60 eligible teeth were allocated in a 1:1 ratio to one of two treatment groups: resin infiltration or enamel microabrasion followed by CPP-ACP application. Allocation was concealed using sequentially numbered, opaque, sealed envelopes. All procedures were performed by one operator under standardized clinical conditions.

In the resin-infiltration group, the lesion surface was treated with 15% hydrochloric acid, rinsed and dried, followed by ethanol application. A low-viscosity resin infiltrant was then applied and light-cured according to the study protocol.

In the microabrasion plus CPP-ACP group, the labial enamel surface was treated with a hydrochloric-acid and silicon-carbide microabrasion material using repeated polishing cycles. CPP-ACP paste was then applied to the treated surface for 5 minutes.

Two co-primary outcomes were evaluated from standardized clinical photographs: the color difference between the lesion and adjacent sound enamel, expressed as ΔE in the CIELab* color space, and the lesion-area ratio, expressed as the percentage of the visible labial tooth surface occupied by the lesion. Images were obtained under reproducible lighting, magnification, camera-positioning, and patient-positioning conditions.

Color measurements were obtained from sampled points within the lesion and adjacent sound enamel. Lesion area and total labial-surface area were outlined and measured using image-analysis software. Outcome assessments were performed by an independent examiner who was blinded to treatment allocation using coded image files. Measurements were obtained before treatment and at prespecified post-treatment and follow-up assessments through 6 months.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

42

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Huế, Vietnam, 530000
        • Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Patients presenting with fluorotic white spot lesions on permanent anterior teeth.
  • Shallow fluorotic white spot lesions confined to the outer enamel.
  • Chalky-white lesions with a clear border from adjacent sound enamel.
  • Lesions appearing bright on oblique visual inspection and mildly dim under diagnostic transillumination.
  • Clinical diagnosis of dental fluorosis based on the characteristic bilateral, symmetrical, and diffuse distribution of enamel opacities.
  • Willingness to participate in the study and comply with treatment and follow-up visits.

Exclusion Criteria:

  • Deep subsurface enamel lesions.
  • Lesions consistent with molar-incisor hypomineralization.
  • Lesions with yellow or brown discoloration.
  • Known allergy or hypersensitivity to ICON, Opalustre, Tooth Mousse, or their components.
  • Inability to tolerate rubber-dam isolation.
  • Poor oral hygiene.
  • Inability or unwillingness to attend the scheduled follow-up assessments.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Resin Infiltration
Eligible fluorotic white spot lesions were treated with resin infiltration using the ICON Vestibular Kit. After rubber-dam isolation, 15% hydrochloric acid was applied for 120 seconds, rinsed for 30 seconds, and air-dried. Ethanol was applied for 30 seconds, and the etching step was repeated if needed. The resin infiltrant was then applied, excess material was removed, and the surface was light-cured according to the study protocol.
After tooth cleaning and rubber-dam isolation, 15% hydrochloric acid was applied to the fluorotic white spot lesion for 120 seconds, rinsed for 30 seconds, and air-dried. Ethanol was applied for 30 seconds to assess lesion masking, and the etching step was repeated if the lesion remained visible. A low-viscosity resin infiltrant was applied for 180 seconds, excess material was removed, and the surface was light-cured for 40 seconds. A second application was performed for 60 seconds and light-cured for an additional 40 seconds.
Comparatore attivo: Microabrasion Plus CPP-ACP
Eligible fluorotic white spot lesions were treated with enamel microabrasion followed by CPP-ACP application. Opalustre containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds. The procedure was repeated for five cycles, followed by application of CPP-ACP gel for 5 minutes.
After tooth cleaning and rubber-dam isolation, an enamel microabrasion material containing 6.6% hydrochloric acid and silicon carbide particles was applied to the labial enamel surface and polished with a rubber cup at approximately 500 rpm for 60 seconds. The surface was rinsed, and the procedure was repeated for five cycles. CPP-ACP paste was then applied to the treated enamel surface for 5 minutes.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
CIELAB Color Difference Between the Fluorotic Lesion and Adjacent Sound Enamel
Lasso di tempo: At baseline and four post-treatment assessments through 6 months (T0-T4)
The color difference between the fluorotic white spot lesion and adjacent sound enamel was measured from standardized clinical photographs in the CIELab* color space. Mean L*, a*, and b* values were obtained from three points within the lesion and three points on adjacent sound enamel located 2 mm from the lesion margin. Color difference was calculated as ΔE = [(ΔL*)² + (Δa*)² + (Δb*)²]¹ᐟ². Lower ΔE values indicate better color matching and lesion masking. A ΔE value below 3.7 was considered not clinically perceptible to the naked eye.
At baseline and four post-treatment assessments through 6 months (T0-T4)
Fluorotic Lesion-Area Ratio on the Labial Tooth Surface
Lasso di tempo: At baseline and four post-treatment assessments through 6 months (T0-T4)
The fluorotic white spot lesion and the visible labial tooth surface were outlined on standardized clinical photographs and measured using ImageJ. The lesion-area ratio was calculated as R (%) = (lesion area / total visible labial surface area) × 100. Scores range from 0% to 100%, with lower values indicating a smaller visible lesion area and better lesion masking.
At baseline and four post-treatment assessments through 6 months (T0-T4)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Van Nhat Thang Le, DDS PhD, Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 giugno 2023

Completamento primario (Effettivo)

30 giugno 2025

Completamento dello studio (Effettivo)

30 giugno 2025

Date di iscrizione allo studio

Primo inviato

10 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 luglio 2026

Primo Inserito (Effettivo)

15 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi